In the News
Celebrate National Internal Medicine Day on Oct. 28
Share your internal medicine pride by posting about National Internal Medicine Day on social media and joining a Twitter chat at 8 p.m. ET on Oct. 28.
Boosters, antithrombotic therapy, mental health effects, more COVID-19 news
FDA advisors recommended booster administration for the Moderna vaccine for certain populations, an ACP/Annals forum covered the immunology of SARS-CoV-2, a trial showed that neither aspirin nor apixaban benefited outpatients with COVID-19, and ACP partnered with YouTube to combat medical misinformation related to COVID-19.
MKSAP Quiz: Right-upper-quadrant abdominal discomfort
A 36-year-old woman is evaluated for a 3-day history of constant right-upper-quadrant abdominal discomfort and abdominal distention. She has no significant medical history. Following a physical exam and lab tests, what is the most appropriate diagnostic test to perform next?
Starting mammography screening at age 40 years in Black women could decrease breast cancer deaths
Breast cancer deaths could be cut by starting mammography screening in Black women 10 years earlier than in White women, a modeling study predicted.
USPSTF pulls back on recommendation of low-dose aspirin for primary prevention
In a draft recommendation statement, the U.S. Preventive Services Task Force (USPSTF) now recommends against initiating low-dose aspirin for the primary prevention of cardiovascular disease in adults ages 60 years or older and says use should be an individual decision in patients ages 40 to 59 years.
U.S. veterans may not always receive preferred treatment for depression
A survey found that more patients strongly preferred psychotherapy than medication, but those who preferred medication and those who preferred psychotherapy did not receive them in 32.1% and 21.8% of cases, respectively.
Put words in our mouth
ACP Internist Weekly wants readers to create captions for our new cartoon and help choose the winner. Pen the winning caption and win a $50 gift certificate good toward any ACP product, program, or service.